News

Presently, there are no antibiotics, systemic or topical, which are specifically approved by the US Food and Drug Administration (FDA) to treat patients with Mild DFI. FDA has

Platine’s laboratories located in Lyon, France, will help clients in the biopharmaceutical, food, cosmetic and diagnostic industries to assess the immunogenicity, activity and efficacy of products during R&D,

The company develops new drug candidates to treat Alzheimer’s disease (AD), other diseases of the central nervous system (CNS) and various types of cancer. Anavex president and chief

As part of the deal, Abic secured rights to market and distribute BELVIQ in Israel for weight loss or weight management in obese and overweight patients, subject to

RG-012 binds to and inhibits the function of microRNA-21 (miR-21), as a therapeutic to treat Alport syndrome, a genetic kidney disease. In the near term, the company intends

PharmaDerm, the branded dermatology business of Sandoz, will be responsible for the sales and marketing of KERYDIN. On July 8, 2014, Anacor announced that the U.S. Food and

This whole process has been part of a company-wide initiative to provide TFS’s clients around the globe with increased performance, functionality and better business decision making tools. OmniComm

The team will collect and integrate previously-siloed medical and research data to advance knowledge and expedite research inquiries for families affected by Phelan-McDermid Syndrome (PMS), a very rare

Stem Cell Factor is a critical cytokine which contributes to cell migration, proliferation, and survival of cardiac stem cells. Researchers at the Cardiovascular Research Center at Icahn School